Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-06

Study Completion Date

2024-09-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: The discovery of aneurysmal or ectatic lesions of the coronary arteries during coronary angiography or coronary CT angiography poses a triple challenge in terms of aetiology, treatment and prognosis. The aim of this study, based on coronary angiograms performed over a 10-year period at the Centre Hospitalier de Versailles, was to determine which antithrombotic treatment was routinely prescribed to patients with ACC or AEC, the evolution of this long-term treatment, and to analyse the association between the presence/absence of anticoagulant treatment and the rates of ischaemic cardiovascular events and haemorrhagic complications.

Materials and methods: This is a non-interventional, observational, single-centre study conducted at the Versailles Hospital Centre from 2013 to 2023, based on the department's coronary angiography registry. The study included adult patients, living or deceased, hospitalised in the cardiology department who underwent coronary angiography between 1 January 2013 and 31 December 2023, which showed the presence of aneurysms or ectatic atheroma with bi- or tri-vessel coronary involvement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence of Major Complication in Case of Thoracic Aortic Aneurysm

NCT05395598

Thoracic Aortic Aneurysm

RECRUITING

Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms

NCT01354821

Aortic Aneurysm

UNKNOWN NA

Safety and Efficacy of Aneurysms Treated With Endovascular Devices

NCT07175519

Brain Aneurysm Stroke Intracranial Hemorrhages

RECRUITING

Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

NCT02323581

Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Thoracic Aortic Dissection, Thoracoabdominal

RECRUITING NA

Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms

NCT03142074

Thoracic Aortic Aneurysms

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Dilatations and Aneursyms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aneurysmal or ectatic lesions of the coronary arteries

This is a non-interventional, observational, single-centre study conducted at the Centre Hospitalier de Versailles from 2013 to 2023, based on the department's coronary angiography registry. The study included adult patients, both living and deceased, who were hospitalised in the cardiology department and underwent coronary angiography between 1 January 2013 and 31 December 2023, which showed the presence of aneurysms or ectatic atheroma with bi- or tri-vessel coronary involvement.

Anticoagulant Treatment

Intervention Type OTHER

Follow-up of patients with coronary aneurysms and treatments introduced (anticoagulants and/or antiplatelet agents) to monitor the onset of ischaemic or haemorrhagic complications between 2013 and 2023.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anticoagulant Treatment

Follow-up of patients with coronary aneurysms and treatments introduced (anticoagulants and/or antiplatelet agents) to monitor the onset of ischaemic or haemorrhagic complications between 2013 and 2023.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Antiplatelet therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient \> 18 years old
* Patient living or deceased
* Patient with aneurysmal or ectatic coronary artery disease with bi- or tri-truncular involvement at coronary angiography.

Exclusion Criteria

* Patient \< 18 years old
* Monotruncal aneurysmal or ectatic disease
* Absence of coronary aneurysm / ectasia
* Patient's opposition to participation in research

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No